Cargando…

Value of phagocyte function screening for immunotoxicity of nanoparticles in vivo

Nanoparticles (NPs) present in the environment and in consumer products can cause immunotoxic effects. The immune system is very complex, and in vivo studies are the gold standard for evaluation. Due to the increased amount of NPs that are being developed, cellular screening assays to decrease the a...

Descripción completa

Detalles Bibliográficos
Autor principal: Fröhlich, Eleonore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454219/
https://www.ncbi.nlm.nih.gov/pubmed/26060398
http://dx.doi.org/10.2147/IJN.S83068
_version_ 1782374579534036992
author Fröhlich, Eleonore
author_facet Fröhlich, Eleonore
author_sort Fröhlich, Eleonore
collection PubMed
description Nanoparticles (NPs) present in the environment and in consumer products can cause immunotoxic effects. The immune system is very complex, and in vivo studies are the gold standard for evaluation. Due to the increased amount of NPs that are being developed, cellular screening assays to decrease the amount of NPs that have to be tested in vivo are highly needed. Effects on the unspecific immune system, such as effects on phagocytes, might be suitable for screening for immunotoxicity because these cells mediate unspecific and specific immune responses. They are present at epithelial barriers, in the blood, and in almost all organs. This review summarizes the effects of carbon, metal, and metal oxide NPs used in consumer and medical applications (gold, silver, titanium dioxide, silica dioxide, zinc oxide, and carbon nanotubes) and polystyrene NPs on the immune system. Effects in animal exposures through different routes are compared to the effects on isolated phagocytes. In addition, general problems in the testing of NPs, such as unknown exposure doses, as well as interference with assays are mentioned. NPs appear to induce a specific immunotoxic pattern consisting of the induction of inflammation in normal animals and aggravation of pathologies in disease models. The evaluation of particle action on several phagocyte functions in vitro may provide an indication on the potency of the particles to induce immunotoxicity in vivo. In combination with information on realistic exposure levels, in vitro studies on phagocytes may provide useful information on the health risks of NPs.
format Online
Article
Text
id pubmed-4454219
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-44542192015-06-09 Value of phagocyte function screening for immunotoxicity of nanoparticles in vivo Fröhlich, Eleonore Int J Nanomedicine Review Nanoparticles (NPs) present in the environment and in consumer products can cause immunotoxic effects. The immune system is very complex, and in vivo studies are the gold standard for evaluation. Due to the increased amount of NPs that are being developed, cellular screening assays to decrease the amount of NPs that have to be tested in vivo are highly needed. Effects on the unspecific immune system, such as effects on phagocytes, might be suitable for screening for immunotoxicity because these cells mediate unspecific and specific immune responses. They are present at epithelial barriers, in the blood, and in almost all organs. This review summarizes the effects of carbon, metal, and metal oxide NPs used in consumer and medical applications (gold, silver, titanium dioxide, silica dioxide, zinc oxide, and carbon nanotubes) and polystyrene NPs on the immune system. Effects in animal exposures through different routes are compared to the effects on isolated phagocytes. In addition, general problems in the testing of NPs, such as unknown exposure doses, as well as interference with assays are mentioned. NPs appear to induce a specific immunotoxic pattern consisting of the induction of inflammation in normal animals and aggravation of pathologies in disease models. The evaluation of particle action on several phagocyte functions in vitro may provide an indication on the potency of the particles to induce immunotoxicity in vivo. In combination with information on realistic exposure levels, in vitro studies on phagocytes may provide useful information on the health risks of NPs. Dove Medical Press 2015-05-26 /pmc/articles/PMC4454219/ /pubmed/26060398 http://dx.doi.org/10.2147/IJN.S83068 Text en © 2015 Fröhlich. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Fröhlich, Eleonore
Value of phagocyte function screening for immunotoxicity of nanoparticles in vivo
title Value of phagocyte function screening for immunotoxicity of nanoparticles in vivo
title_full Value of phagocyte function screening for immunotoxicity of nanoparticles in vivo
title_fullStr Value of phagocyte function screening for immunotoxicity of nanoparticles in vivo
title_full_unstemmed Value of phagocyte function screening for immunotoxicity of nanoparticles in vivo
title_short Value of phagocyte function screening for immunotoxicity of nanoparticles in vivo
title_sort value of phagocyte function screening for immunotoxicity of nanoparticles in vivo
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454219/
https://www.ncbi.nlm.nih.gov/pubmed/26060398
http://dx.doi.org/10.2147/IJN.S83068
work_keys_str_mv AT frohlicheleonore valueofphagocytefunctionscreeningforimmunotoxicityofnanoparticlesinvivo